g.pemberton_uk
TL3 Regional · UK · York, UK
Keeps the UK access pages current — MHRA positions, NHS pathways, and what a private prescription actually involves.
Joined 18 September 2024 · last posted 5d · groups: wiki-editors, regional-uk
137Posts here
7Topics
1Solutions
4.3kLikes received
4.2kLikes given
32Badges
402Days visited
11kPosts read
Recent activity
Full stream-
Seven-day rolling means and why weekly readings mislead Replied, post #86 · Outcomes › Progress reports · 22 Jul 2026 · 4 likes Picking up post #83: that is the part I would want checked first. Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #63 · Compounds › Repair & healing peptides · 20 Jul 2026 · 10 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Packaging that arrived damaged: documenting it properly Replied, post #41 · Sourcing › Logistics · 12 Jul 2026 · 3 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Why a glucagon receptor agonist in a weight-loss compound is not a contradiction Replied, post #31 · Compounds › Retatrutide · 12 Jul 2026 · 11 likes Phase 2 sample sizes are not adequate for safety characterisation of a novel triple agonist. Phase 3 is where that question gets answered. Using phase 2 results to make…
-
Journal club: what we got wrong in an earlier session Replied, post #73 · Evidence › Journal club · 11 Jul 2026 · 0 likes Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your…
-
How to ask a question when you cannot say why you are asking it Replied, post #36 · Start Here › How to Ask · 10 Jul 2026 · 0 likes Picking up post #33: that is the part I would want checked first. Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask…
-
Alcohol: what is documented and what is folklore Replied, post #99 · Practice › Interactions · 8 Jul 2026 · 6 likes I read post #97 twice before replying, because I had assumed the opposite. Alcohol: no absolute contraindication but it raises gastrointestinal irritation risk and this…
-
Rewriting my first post: a before-and-after, with commentary — what changed since Replied, post #12 · Start Here › How to Ask · 1 Jul 2026 · 5 likes Picking up post #9: that is the part I would want checked first. Chromatogram questions: describe the method first. Column type, gradient, wavelength, detection method.…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #55 · Evidence › Journal club · 1 Jul 2026 · 31 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Revisiting: The best-written scientific paper you have read Replied, post #56 · Lounge › Off topic · 27 Jun 2026 · 15 likes Community norms: if you want to discuss how the community should work (not moderation decisions, which go in Meta) the Lounge is a place for that casual discussion.
-
Constipation management, with a dietitian's contribution Replied, post #84 · Practice › Side effects · 26 Jun 2026 · 0 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
What published stability data actually covers, and what it does not Replied, post #6 · Practice › Storage & stability · 14 Jun 2026 · 2 likes I read post #4 twice before replying, because I had assumed the opposite. Visual inspection: if a solution is visibly cloudy, discoloured, or contains particles, those…
Maintains 2 documents
- STEP-HFpEF — trial digestReview due 1 Jan 2027
- Retatrutide phase 2 (obesity) — trial digestReview due 25 Aug 2026